Answers are grounded in this paper and cite their sources.
Acute promyelocytic leukemia (APL) is a unique disease entity in acute myeloid leukemia (AML), characterized by the expansion of leukemic cell block at the promyelocytic stage. The vast majority of APL patients bear t(15;17)(q24;q21) involving the promyelocytic leukemia ( PML ) gene at chromosome
No takes yet. Share an insight, caveat, or question.
Wen et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: